marcus evans europe conferences

2nd Annual Portfolio Management Strategies for Generics and Biosimilars

Foster Performance and Growth in Competitive Markets, Benefit from New Development Opportunities

25-27 Sep 2017
Radisson BLU Hotel, Amsterdam, Netherlands

Refer a Colleague
  1. Wouldn't the world be a better place if we all shared more? If you feel this event could benefit your colleagues current focus then please use the box below to refer the event to them. In doing so you will also do them another good deed in saving them $200 on their registration fee should they wish to attend!

    Please enter the details below to inform your colleague about this event

      Please enter required fields: *Required field

    1. While we hope you can join us for this event, Marcus Evans deliver's over 1000 annual events globally, so if we miss you this time we would love to keep you informed by email of other related events in your specific area of interest. Is that ok?

      Yes    No

  2. Get a new challenge

Conference Speakers

Erez Hybloom
Head Of Portfolio & Launch Management Europe
Teva Pharmaceuticals

Kuntal Chatterjee
Global Business Development Manager

Klemen Spaninger
Global Head of Project Management and Member of the Management Team
Polpharma Biologic

Kirsi Norvasuo-Huber
Head Portfolio Development & Strategic Markets Customers First Lead
Sandoz Germany

rni Hrannar Haraldsson
SVP Business Development & Supply Chain Management
Xantis Pharma AG

Greg Perry
Executive Director
The Medicines Patent Pool

Sameer Agarwal
Senior Vice President-Portfolio & Strategic Marketing, Mature & Emerging Markets
Fresenius Kabi

Peter Wittner
Senior Consultant
Interpharm Consultancy

Latest Conference news

Venue map

Social Media
Twitter Updates

General Enquiries

For all enquiries regarding speaking, sponsoring and attending this conference contact:

Yiota Andreou

marcus evans (Europe) Ltd
PO Box 24797

+357 22 849 404
Fax: +357 22 849 310

Conference Quote

Foster Performance and Growth in Competitive Markets, Benefit from New Development Opportunities